MAVS integrates glucose metabolism and RIG-I-like receptor signaling

Qiao-Qiao He1, Yu Huang1, Longyu Nie1

  • 1State Key Laboratory of Virology, Modern Virology Research Center, Frontier Science Center for Immunology and Metabolism, College of Life Sciences, Wuhan University, Wuhan, 430072, China.

Nature Communications
|September 2, 2023
PubMed

Insights

Mitochondrial antiviral signaling (MAVS) protein regulates glucose metabolism by shifting pathways like glycolysis to the pentose phosphate pathway (PPP) and hexosamine biosynthesis pathway (HBP). Peroxisomal and MAMs-associated MAVS have distinct roles in this metabolic reprogramming and interferon signaling.

Area of Science:

  • Immunology
  • Cell Biology
  • Metabolic Pathways

Background:

  • Mitochondrial antiviral signaling (MAVS) protein is crucial for RIG-I-like receptor (RLR) signaling.
  • The precise roles of MAVS in glucose metabolism and its cross-regulation with RLR signaling across organelles remain unclear.
  • Understanding how these pathways are coordinated is essential for deciphering cellular defense mechanisms.

Purpose of the Study:

  • To investigate the role of MAVS in glucose metabolism.
  • To elucidate the cross-regulation between RLR signaling and glucose metabolism.
  • To define the organelle-specific functions of MAVS in coordinating these pathways.

Main Methods:

  • Investigated MAVS localization and function in peroxisomes and mitochondria-associated ER membranes (MAMs).
  • Analyzed glucose flux shifts using metabolic pathway tracing.
  • Identified protein-protein interactions within MAVS signalosomes using co-immunoprecipitation and Western blotting.

Main Results:

  • RLR activation via MAVS promotes a metabolic switch from glycolysis to the pentose phosphate pathway (PPP) and hexosamine biosynthesis pathway (HBP).
  • Peroxisomal MAVS directs glucose flux to PPP and induces type III interferon expression.
  • MAMs-associated MAVS directs glucose flux to HBP and induces type I interferon expression, involving specific protein interactions like G6PD and glutamine-fructose-6-phosphate transaminase.

Conclusions:

  • MAVS acts as a critical mediator linking RLR signaling with glucose metabolism.
  • Organelle-specific localization of MAVS dictates distinct metabolic and immune signaling outcomes.
  • This study reveals a novel mechanism of metabolic reprogramming orchestrated by MAVS during innate immune responses.

Related Concept Videos

Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.7K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.3K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.3K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
3.5K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
358
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.5K